Pharvaris (PHVS) Total Liabilities (2019 - 2026)

Pharvaris (PHVS) posted Total Liabilities of $27.5 million for Q1 2026, down 21.84% on a QoQ basis from $35.1 million in Q4 2025, and up 14.88% year-over-year from $23.9 million in Q1 2025.

Pharvaris (PHVS) Total Liabilities (2019 - 2026) Analysis & Trends

Pharvaris' Total Liabilities history runs 8 years deep, the most recent figure standing at $27.5 million for Q1 2026.

  • Quarterly Total Liabilities rose 14.88% year-over-year to $27.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.5 million (up 14.88% YoY) and the FY2025 annual result came in at $34.1 million, up 33.41% from the prior year.
  • Total Liabilities was $27.5 million for Q1 2026 at Pharvaris, down from $35.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $35.1 million in Q4 2025 and bottomed at $11.5 million in Q1 2022.
  • A 5-year average of $21.6 million and a median of $20.0 million in 2024 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2022 — Total Liabilities jumped 130.85% — and 2023, when it declined 16.39%.
  • Pharvaris' Total Liabilities stood at $18.8 million in 2022, then declined by 16.39% to $15.8 million in 2023, then soared by 60.13% to $25.2 million in 2024, then jumped by 39.22% to $35.1 million in 2025, then decreased by 21.84% to $27.5 million in 2026.
  • Business Quant data shows PHVS's Total Liabilities at $27.5 million in Q1 2026, $35.1 million in Q4 2025, and $31.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 60.46 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 177.22 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 19.51 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 3.79 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.48 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 753.82 Mn
10 Pharvaris 2.22 Bn 1.94 Bn - 27.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.46 Mn
Dec 31, 2025 35.13 Mn
Sep 30, 2025 31.16 Mn
Jun 30, 2025 28.84 Mn
Mar 31, 2025 23.90 Mn
Dec 31, 2024 25.23 Mn
Sep 30, 2024 18.00 Mn
Jun 30, 2024 20.54 Mn
Mar 31, 2024 20.02 Mn
Dec 31, 2023 15.76 Mn
Sep 30, 2023 17.65 Mn
Jun 30, 2023 17.44 Mn
Mar 31, 2023 20.02 Mn
Dec 31, 2022 18.85 Mn
Sep 30, 2022 17.96 Mn
Jun 30, 2022 17.25 Mn
Mar 31, 2022 11.50 Mn
Dec 31, 2021 8.16 Mn
Sep 30, 2021 9.04 Mn
Jun 30, 2021 9.03 Mn